An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how antibody medicines are tested and brought to patients. The work, published ...

Australian researchers have developed a powerful new way to target deadly, drug-resistant bacteria by designing antibodies ...

Antibodies are the immune system's precision tools for recognizing and neutralizing viruses, bacteria and other foreign ...

One expert explains how bispecific antibodies are a ‘targeted and effective’ option for patients with multiple myeloma. Bispecific antibodies offer a “targeted and effective alternative” for the ...

Scientists have identified a new pair of antibodies that could fend off multiple COVID-19 variants. Found in people who ...

When administered to animals infected with multidrug‑resistant A. baumannii, the antibodies enhanced phagocytosis.

COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health ...

Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps explain why ...

The race is on for new treatments that stand up to omicron's explosive spread. With omicron's explosive spread threatening to outpace current COVID-19 treatments, the race is on to find new options ...

An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how antibody medicines are tested and brought to patients. The work, published ...

Dr. Amany Keruakous discussed how bispecific antibodies for multiple myeloma work by simultaneously targeting cancer cells and T cells. Dr. Amany Keruakous sat down for an interview with CURE, in ...